Marion McCourt - 01 Feb 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: EVP Commercial
Signature: /s/** Marion McCourt
Issuer symbol: REGN
Transactions as of: 01 Feb 2022
Net transactions value: -$264,530
Form type: 4
Filing time: 02 Feb 2022, 15:14:16 UTC
Previous filing: 05 Jan 2022
Next filing: 03 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Options Exercise	$342,930	+1,000	+5.1%	$342.93	20,644	01 Feb 2022	Direct	F1
transaction	REGN	Common Stock	Sale	$607,460	-1,000	-4.8%	$607.46	19,644	01 Feb 2022	Direct	F1
holding	REGN	Common Stock						116	01 Feb 2022	By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	REGN	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-1,000	-11%	$0.000000	8,000	01 Feb 2022	Common Stock	1,000	$342.93	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2	The stock option award vests in four equal annual installments, commencing one year after the date of grant.